September 5, 2025Open Access

Figure S2 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis shows that high EGFR correlates with worse outcomes in NF1 mutant melanoma, suggesting a potential for targeted therapy.

High levels of EGFR expression lead to poorer outcomes in patients with NF1 mutant melanoma, unlike those with BRAF or NRAS mutations.
The study indicates that NF1 loss promotes EGFR activation, creating a dependency on EGFR signaling for melanoma cell survival.
Understanding the relationship between NF1 mutation and EGFR sensitivity might enhance treatment strategies for melanoma.
These findings highlight the potential of targeting EGFR in NF1 mutant melanoma to improve patient outcomes.

Ibrahim et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 5, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis shows that high EGFR correlates with worse outcomes in NF1 mutant melanoma, suggesting a potential for targeted therapy.

High levels of EGFR expression lead to poorer outcomes in patients with NF1 mutant melanoma, unlike those with BRAF or NRAS mutations.
The study indicates that NF1 loss promotes EGFR activation, creating a dependency on EGFR signaling for melanoma cell survival.
Understanding the relationship between NF1 mutation and EGFR sensitivity might enhance treatment strategies for melanoma.
These findings highlight the potential of targeting EGFR in NF1 mutant melanoma to improve patient outcomes.

Ibrahim et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark